N/A N=9

Clinical Application of BioCleanse Meniscus

Tear of Meniscus of Knee

Bottom Line

View on ClinicalTrials.gov: NCT00659880 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2017

Primary outcome: Primary: Knee Injury and Osteoarthritis Outcome Score (KOOS) — 70.1 units on a scale — p=0.06

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: BioCleanse Meniscus (Other)
Age: Adult · 18+ yrs
Sex: All
Sponsor: RTI Surgical
Primary completion: Jul 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Knee Injury and Osteoarthritis Outcome Score (KOOS)	70.1	0.06
SECONDARY MRI Assessments	4; 3; 4; 2; 1; 0	—

Summary

This study will follow patients after routine surgery of a meniscal allograft transplant.

Eligibility Criteria

Inclusion Criteria

All patients, up to 10 who have selected a BioCleanse Meniscus transplant

Exclusion Criteria

Anyone not eligible for a meniscal transplant

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00659880). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.